Recursion Pharmaceuticals (RXRX) Change in Receivables (2020 - 2021)
Recursion Pharmaceuticals (RXRX) posted Change in Receivables of -$16000.0 for Q3 2021, down 23.08% on a QoQ basis from -$13000.0 in Q2 2021, and down 100.05% year-over-year from $30.2 million in Q3 2020.
Recursion Pharmaceuticals (RXRX) Change in Receivables (2020 - 2021) Analysis & Trends
Recursion Pharmaceuticals' Change in Receivables history runs 2 years deep, the most recent figure standing at -$16000.0 for Q3 2021.
- Quarterly Change in Receivables fell 100.05% year-over-year to -$16000.0 in Q3 2021, while the trailing twelve-month figure through Dec 2021 was -$114000.0 (down 2380.0% YoY) and the FY2021 annual result came in at -$114000.0, down 2380.0% from the prior year.
- Change in Receivables was -$16000.0 for Q3 2021 at Recursion Pharmaceuticals, down from -$13000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $30.2 million in Q3 2020 and bottomed at -$30.0 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.59 Bn | 933.22 Mn | -6.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -16,000.00 |
| Sep 30, 2021 | -16,000.00 |
| Jun 30, 2021 | -13,000.00 |
| Jun 30, 2021 | -13,000.00 |
| Mar 31, 2021 | -85,000.00 |
| Mar 31, 2021 | -85,000.00 |
| Dec 31, 2020 | -30.04 Mn |
| Dec 31, 2020 | -30.04 Mn |
| Sep 30, 2020 | 30.19 Mn |
| Sep 30, 2020 | 30.19 Mn |
| Jun 30, 2020 | -60,000.00 |
| Jun 30, 2020 | -60,000.00 |
| Mar 31, 2020 | -82,000.00 |
| Mar 31, 2020 | -82,000.00 |